Teramoto Noriyoshi, Zhu Hai-Lei, Ito Yushi
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.
J Pharm Pharmacol. 2004 Mar;56(3):395-9. doi: 10.1211/0022357022755.
The inhibitory effects of glibenclamide on the levcromakalim-induced ATP-sensitive K+ (K(ATP)) channels were investigated with cell-attached configuration in pig proximal urethra. Application of 10 microM glibenclamide reversibly inhibited the activity of the 100 microM levcromakalim-induced K(ATP) channel, decreasing not only the channel open probability but also the amplitude of unitary current. The inhibitory concentration-response curve of the glibenclamide-induced sublevel conductance of K(ATP) channel was shifted to the right (IC50 = 4.7 microM), compared with the levcromakalim-induced K(ATP) channel (full conductance, IC50 = 0.5 microM). Glibenclamide is the first reported sulphonylurea to selectively block K(ATP) channel, not only by decreasing the channel activity but also by reducing the unitary amplitude in smooth muscle.
采用细胞贴附式膜片钳技术,在猪近端尿道研究了格列本脲对左旋克罗卡林诱导的ATP敏感性钾通道(K(ATP)通道)的抑制作用。应用10 μM格列本脲可可逆性抑制100 μM左旋克罗卡林诱导的K(ATP)通道活性,不仅降低通道开放概率,还降低单通道电流幅度。与左旋克罗卡林诱导的K(ATP)通道(全电导,IC50 = 0.5 μM)相比,格列本脲诱导的K(ATP)通道亚电导抑制浓度-反应曲线右移(IC50 = 4.7 μM)。格列本脲是首个被报道的选择性阻断K(ATP)通道的磺脲类药物,它不仅可降低通道活性,还可减小平滑肌中的单通道电流幅度。